|
1
|
Liu J, Wu D, Ahmed A, Li X, Ma Y, Tang L,
Mo D, Ma Y and Xin Y: Comparison of the gut microbe profiles and
numbers between patients with liver cirrhosis and healthy
individuals. Curr Microbiol. 65:7–13. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Guo RY, Chen ZJ, Chen N and Chen Y:
Quantitative real-time PCR analysis of intestinal regular fungal
species in fecal samples from patients with chronic hepatitis B
virus infection. Lab Med. 41:591–596. 2010. View Article : Google Scholar
|
|
3
|
Lu H, Wu Z, Xu W, Yang J, Chen Y and Li L:
Intestinal microbiota was assessed in cirrhotic patients with
hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic
patients. Microb Ecol. 61:693–703. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Seo YS and Shah VH: The role of gut-liver
axis in the pathogenesis of liver cirrhosis and portal
hypertension. Clin Mol Hepatol. 18:337–346. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cesaro C, Tiso A, Del Prete A, Cariello R,
Tuccillo C, Cotticelli G, Del Vecchio Blanco C and Loguercio C: Gut
microbiota and probiotics in chronic liver diseases. Dig Liver Dis.
43:431–438. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rehermann B and Nascimbeni M: Immunology
of hepatitis B virus and hepatitis C virus infection. Nat Rev
Immunol. 5:215–229. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang Q, Pan YF and Ping XG: The hepatitis
C virus (HCV) RNA load changes in chronic hepatitis C HCV-related
liver cirrhosis and HCV-related hepatocellular carcinoma groups and
genotype effects on disease progression. J Med Forum. 35:349–353.
2014.
|
|
8
|
Abu Mouch S, Fireman Z, Jarchovsky J,
Zeina AR and Assy N: Vitamin D supplementation improves sustained
virologic response in chronic hepatitis C (genotype 1) - naïve
patients. World J Gastroenterol. 17:5184–5190. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Eckburg PB, Bik EM, Bernstein CN, Purdom
E, Dethlefsen L, Sargent M, Gill SR, Nelson KE and Relman DA:
Diversity of the human intestinal microbial flora. Science.
308:1635–1638. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Grice EA and Segre JA: The human
microbiome: Our second genome. Annu Rev Genomics Hum Genet.
13:151–170. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
McKenna P, Hoffmann C, Minkah N, Aye PP,
Lackner A, Liu Z, Lozupone CA, Hamady M, Knight R and Bushman FD:
The macaque gut microbiome in health, lentiviral infection, and
chronic enterocolitis. PLoS Pathog. 4:e202008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dethlefsen L, Huse S, Sogin ML and Relman
DA: The pervasive effects of an antibiotic on the human gut
microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol.
6:e2802008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Turnbaugh PJ, Hamady M, Yatsunenko T,
Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA,
Affourtit JP, et al: A core gut microbiome in obese and lean twins.
Nature. 457:480–484. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vaishnavi C: Fecal microbiota
transplantation for management of Clostridium difficile infection.
Indian J Gastroenterol. 33:301–307. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pompei A, Cordisco L, Amaretti A, Zanoni
S, Matteuzzi D and Rossi M: Folate production by bifidobacteria as
a potential probiotic property. Appl Environ Microbiol. 73:179–185.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cani PD, Neyrinck AM, Fava F, Knauf C,
Burcelin RG, Tuohy KM, Gibson GR and Delzenne NM: Selective
increases of bifidobacteria in gut microflora improve
high-fat-diet-induced diabetes in mice through a mechanism
associated with endotoxaemia. Diabetologia. 50:2374–2383. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen Y, Yang F, Lu H, Wang B, Chen Y, Lei
D, Wang Y, Zhu B and Li L: Characterization of fecal microbial
communities in patients with liver cirrhosis. Hepatology.
54:562–572. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lamousé-Smith ES, Tzeng A and Starnbach
MN: The intestinal flora is required to support antibody responses
to systemic immunization in infant and germ free mice. PLoS One.
6:e276622011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kolls JK and Lindén A: Interleukin-17
family members and inflammation. Immunity. 21:467–476. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang X, Angkasekwinai P, Dong C and Tang
H: Structure and function of interleukin-17 family cytokines.
Protein Cell. 2:26–40. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Semedo T, Almeida Santos M, Martins P,
Silva Lopes MF, Figueiredo Marques JJ, Tenreiro R and Barreto
Crespo MT: Comparative study using type strains and clinical and
food isolates to examine hemolytic activity and occurrence of the
cyl operon in enterococci. J Clin Microbiol. 41:2569–2576. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang JY, Zhang Z, Lin F, Zou ZS, Xu RN,
Jin L, Fu JL, Shi F, Shi M, Wang HF, et al:
Interleukin-17-producing CD4(+) T cells increase with
severity of liver damage in patients with chronic hepatitis B.
Hepatology. 51:81–91. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Parfieniuk-Kowerda A, Jaroszewicz J and
Flisiak R: Immune regulation and viral diversity as correlates of
natural and treatment induced immune control in persistent
hepatitis B virus (HBV) infection. Clin Exp Hepatol. 1:35–38. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schuppan D and Afdhal NH: Liver cirrhosis.
Lancet. 371:838–851. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bouillon R, Carmeliet G, Verlinden L, van
Etten E, Verstuyf A, Luderer HF, Lieben L, Mathieu C and Demay M:
Vitamin D and human health: Lessons from vitamin D receptor null
mice. Endocr Rev. 29:726–776. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Suibhne TN, Cox G, Healy M, O'Morain C and
O'Sullivan M: Vitamin D deficiency in Crohn's disease: Prevalence,
risk factors and supplement use in an outpatient setting. J Crohn's
Colitis. 6:182–188. 2012. View Article : Google Scholar
|
|
27
|
Arteh J, Narra S and Nair S: Prevalence of
vitamin D deficiency in chronic liver disease. Dig Dis Sci.
55:2624–2628. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Malham M, Jørgensen SP, Ott P, Agnholt J,
Vilstrup H, Borre M and Dahlerup JF: Vitamin D deficiency in
cirrhosis relates to liver dysfunction rather than aetiology. World
J Gastroenterol. 17:922–925. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Petta S, Cammà C, Scazzone C, Tripodo C,
Di Marco V, Bono A, Cabibi D, Licata G, Porcasi R, Marchesini G, et
al: Low vitamin D serum level is related to severe fibrosis and low
responsiveness to interferon-based therapy in genotype 1 chronic
hepatitis C. Hepatology. 51:1158–1167. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zúñiga S, Firrincieli D, Housset C and
Chignard N: Vitamin D and the vitamin D receptor in liver
pathophysiology. Clin Res Hepatol Gastroenterol. 35:295–302. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Drocourt L, Ourlin JC, Pascussi JM, Maurel
P and Vilarem MJ: Expression of CYP3A4, CYP2B6, and CYP2C9 is
regulated by the vitamin D receptor pathway in primary human
hepatocytes. J Biol Chem. 277:25125–25132. 2002. View Article : Google Scholar : PubMed/NCBI
|
